Benzinga's options scanner has just identified more than 10 option transactions on Janux Therapeutics JANX, with a cumulative value of $516,310. Concurrently, our algorithms picked up 4 puts, worth a total of 166,310.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $60.0 for Janux Therapeutics during the past quarter.
Insights into Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Janux Therapeutics's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Janux Therapeutics's substantial trades, within a strike price spectrum from $50.0 to $60.0 over the preceding 30 days.
Janux Therapeutics Call and Put Volume: 30-Day Overview
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JANX | CALL | SWEEP | BULLISH | 05/17/24 | $7.0 | $6.9 | $7.0 | $50.00 | $191.1K | 865 | 616 |
| JANX | PUT | SWEEP | BULLISH | 06/21/24 | $9.0 | $7.3 | $7.3 | $55.00 | $73.0K | 299 | 1 |
| JANX | CALL | SWEEP | BULLISH | 05/17/24 | $7.0 | $6.9 | $7.0 | $50.00 | $50.4K | 865 | 0 |
| JANX | CALL | SWEEP | BULLISH | 05/17/24 | $7.0 | $6.9 | $7.0 | $50.00 | $41.3K | 865 | 116 |
| JANX | CALL | TRADE | BEARISH | 05/17/24 | $3.0 | $2.0 | $2.0 | $60.00 | $40.0K | 1.3K | 0 |
About Janux Therapeutics
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
Following our analysis of the options activities associated with Janux Therapeutics, we pivot to a closer look at the company's own performance.
Janux Therapeutics's Current Market Status
- With a trading volume of 666,689, the price of JANX is down by -11.48%, reaching $54.44.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 90 days from now.
Professional Analyst Ratings for Janux Therapeutics
2 market experts have recently issued ratings for this stock, with a consensus target price of $72.0.
- In a cautious move, an analyst from JonesTrading downgraded its rating to Buy, setting a price target of $70.
- Maintaining their stance, an analyst from Wedbush continues to hold a Outperform rating for Janux Therapeutics, targeting a price of $74.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Janux Therapeutics with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
